A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. During her time at CNET, Kim ...

The FreeStyle Libre 3 system consists of the sensor around the size of a £1 coin that is worn on the upper arm and an app which can be used by users to record their real-time glucose levels and ...

A CGM helps me run marathons and do epic bike rides better than ever.

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose ... saying its FreeStyle Libre system’s LibreLinkUp ...

In our view, Abbott's FreeStyle Libre blood glucose monitor franchise is one of the most compelling innovations the firm has ever launched. Further, the pandemic provided a boon to the diagnostics ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...